Towson, MDNCT07332000Now EnrollingIRB Ready

Prostate Cancer Patients Treated by Radiotherapy Clinical Trial in Towson, MD

Access cutting-edge prostate cancer patients treated by radiotherapy treatment through this clinical trial at a research site in Towson. Study-provided care at no cost to qualified participants.

Sponsored by Candel Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Towson location

Preparing your pre-screening questions…

Expert Care in Towson

Access prostate cancer patients treated by radiotherapy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related prostate cancer patients treated by radiotherapy treatment provided free

Apply for This Towson Location

Check if you qualify for this prostate cancer patients treated by radiotherapy clinical trial in Towson, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Towson

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Towson site if eligible
  4. 4Begin participation

About This Prostate Cancer Patients Treated by Radiotherapy Study in Towson

Phase 2a, open-label, multi-center study evaluating biomarkers and biodistribution of aglatimagene besadenovec plus valacyclovir in men with localized, intermediate-risk prostate cancer who are planning to receive external beam radiation therapy (EBRT).

Sponsor: Candel Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

Participants must give study-specific informed consent prior to enrollment
Histologically confirmed adenocarcinoma of the prostate
Participants meeting National Comprehensive Cancer Network (NCCN) intermediate-risk criteria
Participants must be planning and medically able to undergo standard or moderate hypofractionated prostate-only EBRT (treatment and control group) and able to tolerate multiple transrectal ultrasound guided injections (treatment group only)
18 years of age or older
Performance status must be Eastern Cooperative Oncology Group 0-2
The following laboratory criteria must be met (treatment group only):
Aspartate aminotransferase (AST) \< 3 x upper limit of normal
Serum creatinine \< 2 mg/dL
Calculated creatinine clearance \> 30 mL/min
White blood cells \> 3000/mm3
Platelets \>100,000/mm3

Exclusion Criteria

Active liver disease, including known cirrhosis or active hepatitis
Participants on systemic corticosteroids (\> 10 mg prednisone per day) or other immunosuppressive drugs
Known HIV+ participants
Regional lymph node involvement or distant metastases
Participants planning to receive whole pelvic irradiation
Other current malignancy (except squamous or basal cell skin cancers)
Other serious co-morbid illness or compromised organ function that, in the opinion of the Investigator, would interfere with treatment or follow-up. For example, participants with diseases that preclude radiation therapy to the prostate such as severe prostatitis and inflammatory bowel disease.
Prior treatment for prostate cancer except transurethral resection of the prostate (TURP). If prior TURP, participants must be deemed able to receive multiple intra-prostatic injections by the Investigator.
Participants who had or plan to have orchiectomy as the form of hormonal ablation
Known sensitivity or allergic reactions to acyclovir or valacyclovir (treatment group only)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Towson?

Yes, this clinical trial (NCT07332000) has an active research site in Towson, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Prostate Cancer Patients Treated by Radiotherapy Treatment Options in Towson, MD

If you're searching for prostate cancer patients treated by radiotherapy treatment options in Towson, MD, this clinical trial (NCT07332000) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Towson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer patients treated by radiotherapy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all prostate cancer patients treated by radiotherapy clinical trials near you to find additional studies recruiting in your area.

More Prostate Cancer Trials in Towson, MD

See all prostate cancer clinical trials recruiting in Towson — not just this study.

Browse Prostate Cancer Trials in Towson →

Browse More Trials by Condition

Prostate Cancer TrialsAlzheimers Disease TrialsRheumatoid Arthritis TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in Towson?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Towson, MD